Products from BPS Bioscience require a minimum order value above 400€
Encompassing Amino Acids: 187-end
Applications: Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.
Assay Conditions: ALK3 (Q233D) activity was measured by using the TGFBR1 peptide substrate (KKKVLTQMGSPSIRCS(pS)VS) diluted in distilled water to a working concentration of 1 mg/ml, in a [33P]-ATP based assay. Reaction was initiated by mixing increasing amounts of ALK3 (Q233D) with 1250 pmoles of [33P]-ATP in 5 mM MOPS, pH 7.2, 2.5 mM ?-glycerol-phosphate, 5 mM MgCl2, 0.4 mM EDTA, 50 ng/µl BSA prepared with 50 µM DTT, 50 µM ATP and substrate at a final concentration of 200 µg/ml.The reaction was initiated by addition of [33P]-ATP Assay Cocktail, followed by a 15-minute incubation at 30°C. The reaction was terminated by spotting the reaction mixture on phosphocellulose P81 paper, air-dry and three 10-minute washes with 1% phosphoric acid solution. Radioactivity was measured in a scintillation counter. The corrected activity (RLU) was calculated by removing the blank value for each sample. The Kinase Specific Activity was calculated as follows: RLU / [(specific activity of [33P]-ATP in cpm/pmol)*(Reaction time in min)*(Enzyme amount in µg or mg)] * [(Reaction Volume) / (Spot Volume)]. The blank was determined from a "no substrate"sample by replacing the substrate solution with an equal volume of distilled water.
Background: ALK3 (bone morphogenetic protein receptor type IA), also known as BMPR1A or CD292 (cluster of differentiation 292), is a bone morphogenic protein receptor involved in BMP (bone morphogenic protein) signal transduction. ALK3 maintains cell stemness by inhibiting Wnt signaling. It is involved in juvenile polyposis syndrome, Cowden's disease and kidney injury. The development of inhibitors and agonists may provide new therapeutic opportunities for the regeneration and repair of kidney.
Description: Recombinant human ALK3 (Q233D) (bone morphogenetic protein receptor IA), encompassing amino acids 187-end with an Q233D mutation. This construct contains an N-terminal GST-tag. The recombinant protein was affinity purified and is active.
Format: Aqueous buffer solution
Formulation: 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM Glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, 25% glycerol
Genbank: NM_004329
Purity: ≥90% (Purity calculation does not include co-purifying Glutathione-binding proteins.)
Storage Stability: At least 6 months at -80°C.
Tags: N-terminal GST-tag
Uniprot: P36894
Warnings: Avoid freeze/thaw cycles
Biosafety Level: Not applicable (BSL-1)
English
Deutsch
